Refine your search
Collections
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mythili, L.
- Ocular Drug Delivery System–An Update Review
Abstract Views :231 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund. (Affiliated to JSS Academy of Higher Education and Research, Mysuru), IN
1 Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund. (Affiliated to JSS Academy of Higher Education and Research, Mysuru), IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 5 (2019), Pagination: 2527-2538Abstract
Eye being a unique and complex organ the access of exogenous substances to the ocular tissues are restricted by its physiology and defense mechanism. Thus the delivery of therapeutic agents to the ocular tissues is not an easy assignment. Cornea an important component present in eye is protected by very effective protective mechanisms which provide the pharmaceutical scientists a challenge of designing a formulation and delivering it to the targeted sites in sufficient concentrations. Development of newer approaches and novel therapeutic agents continue to provide delivery system a high therapeutic efficacy. Due to the defects in the traditional treatment, and also the therapeutic drug levels in targeted site is not maintained for longer time, the search of new type of ophthalmic approaches and technologies has drawn more and more attentions. In past two decades research in ocular delivery system have been accelerated towards a novel, safe and patient compliance formulation and medical devices to surpass the barriers and maintain the therapeutic level in tissues. Recently various technologies with good efficacy and biocompatibility have also been developed to treat the ocular diseases at both the anterior and posterior portion of eye. Anterior segment approaches for ocular treatment, advances are witnessed through the modulation of conventional topical drops with permeation enhancers and it also includes the development as ointments, gels etc. Several nano-formulations are also introduced for treating the anterior portion of the eye. Furthermore for posterior delivery, research focused immensely towards the development of releasing devices and also nano-formulation. Therefore these novel approaches and devices are easy to formulate, possess negligible irritation, prolonged precorneal residence time, sustained drug release, and enhanced bioavailability. An update of research advancement in ocular drug delivery provides and helps the scientists to modulate and develop safe drug delivery strategies. This review article gives update information about various approaches for delivering the drug to ocular region.Keywords
Eye, Ocular Drug Delivery, Barriers, Conventional Drug Delivery, Novel Dosage Form, Approaches.References
- Ashim K. Mitra. Textbook of Ophthalmic Drug Delivery Systems. Drugs and the Pharmaceutical Sciences.2nd Edition, Revised and Expanded.
- Ripal Gaudana, J.Jwala, Sai H. S. Boddu, Ashim K. Mitra. Recent Perspectives in Ocular Drug Delivery. Pharmaceutical Research, Vol May2009; 26:No.5.
- K. P. Sampath Kumar, Debjit Bhowmik, Shravan Paswan, Shweta Srivastava. Recent challenges and advances in Ophthalmic drug delivery system. The Pharma Innovation.2012; Vol.No.4.
- Patel PB, Shastri DH, Shelat PK, Shukla A K. Ophthalmic Drug Delivery System: Challenges and Approaches. Systematic Reviews in Pharmacy. 2010; Vol 1:Issue 2.
- Upendra Kumar Sharma, Amita Verma, Sunil Kumar Prajapati, Himanshu Pandey. Ocular drug delivery: Assorted Obstructions and Contemporary progresses. International Journal of Research and Development in Pharmacy and Life sciences.2013; Vol 2:No 4, pp 464-473.
- Vincent H. L. Lee, Joseph R.Robinson. Review: Topical Ocular drug delivery: Recent developments and future challenges.1986; Vol 2: pp 67-108.
- Pawar Pravin, Yadav Adhikrao, Gharge Varsha. Ocular drug delivery and Novel formulation: A review. Asian journal of Pharmacy and Technology.2018; Vol 8(4).
- Ashaben Patel, Kishore Cholkar, Vibhuti Agrahari, Ashim K Mitra. Ocular drug delivery systems: An overview. World Journal of Pharmacology.2013June9; 2(2):47-64.
- Noriyuki Kuno, Shinobu Fujii. Recent Advances in Ocular drug delivery systems. Polymers 2011; 3:193-221.
- Foziyah Zakir, Singh Manvi, Iqbal Zeenat.Ocular drug delivery:Recent updates. International Journal of Drug Regulatory Affairs, 2016; 4(4):15-22.
- Divya Gupta.Review on Ocular drug delivery. Pharmatutor Pharmacy Infopedia.2018.
- Chrystete Le Bourlais, Liliane Acar, Hosein Zia, Pierre A. Sado, Thomas Needham, Roger Leverge. Ophthalmic Drug Delivery Systems-Recent Advances. January 1998; Vol 17:Issue 1:33-58p.
- Kritika Nayak, Manju Misra.A review on recent drug delivery systems for posterior segment of eye. Biomedicine and Pharmacotherapy. Elsevier; 2018; 107:1564-82.
- Kristiina Jarvinen, Tomi Jarvinen, Arto Urtti. Ocular absorption following topical delivery. Advanced drug delivery reviews. Elsevier.1995; 16: 3-19.
- Saiichi Mishima, MD.Some Physiological aspects of the Precorneal Tear film. Arch Ophthalmol.1965; 73(2):233-241.
- Ingrida Januleviciene, Lina Siaudvytyte, Ruta Barsauskaite. Opthalmic drug delivery in Glaucoma-A review. Research Gate.2012; 4(1):243-251.
- Shravan Kumar Paswan, Pritt Verma, Mahendra Singh Yadav. Review-Advance Technique in Ocular drug delivery system. World journal of Pharmacy and Pharmaceutical sciences.2015; Vol 4:346-365.
- Mittanamalli S Sridhar. Anatomy of cornea and ocular surface. Indian Journal of Ophthalmology.2018; 66(2):190-194.
- Revathy V. Nair, Sreeja C. Nair, Anoop K. R. Current trends in Ocular drug systems and its applications. Research Journal of Pharmacy and Technology.2015; 8(5).
- Kishore Cholkar, Supriya Reddy Dasari, Dhananjay Pal and Ashim K Mitra. Eye: Anatomy, Physiology and Barriers to drug delivery. Research Gate.2013; 1-36p.
- Ripal Gaudana, Hari Krishna Ananthula, Ashwin Parenky, Ashim K. Mitra. Ocular drug delivery. American Association of Pharmaceutical Scientists Journal.2010; Vol 12:No.3.
- Nathaniel J. Kim, Alon Harris, Alhasan Elghouche, Willy Gama, and Brent Siesky. Ocular Permeation Enhancers. Nano-Biomaterials for Ophthalmic drug delivery.177-209p.
- Hao Chen, Yingying Jin, Lin Sun, Xi Li, Kaihui Nan, Huihua Lia. Recent development in ophthalmic drug delivery systems for therapy of both anterior and posterior segment diseases. Colloid and Interface Science Communications.Elsevier.2018; 24(March):54-61.
- Indu Pal Kaur, R.Smitha. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug delivery and Industrial pharmacy.2002; 28(4):353-369.
- Ramaiyan Dhanapal, J.Vijaya Ratna. Ocular drug delivery system-A review. International Journal of Innovative drug discovery.2012; Vol 2:Issue 1:4-15.
- Peter WJ Morrison and Vitaliy V Khutoryanskiy. Advances in ophthalmic drug delivery. Therapeutic Delivery.2014; 5(12):1297-1315.
- John C. Lang. Ocular drug delivery conventional ocular formulations. Advanced drug delivery reviews.1995:16(1):39-43.
- Akanksha Tiwari, Raj Kumar Shukla. Novel ocular drug delivery systems: An overview. Journal of Chemical and Pharmaceutical research.2010; 2(3):348-355.
- P. Tangri, S. Khurana. Basics of Ocular drug delivery systems. International Journal of Research in Pharmaceutical and Biomedical sciences.2011; Vol 2(4).
- K. S. Rathore, R. K. Nema, S. S. Sisodia. An overview and advancement in ocular drug delivery systems. International Journal of Pharmaceutical sciences and research.2010; Vol 1(10):11-23.
- Yasmin Sultana, R Jain, M. Aqil and Asgar Ali. Review of Ocular drug delivery. Current drug delivery.2006; 3(2):207-217.
- Patel Vishal, Agarwal Y.K. Current status and advanced approaches in ocular drug delivery system. Journal of Global Trends in Pharmaceutical Sciences.2011; Vol 2(2):pp 131-148.
- Monali N. Dumore, Mahesh R. Mishra, Nitin G Dumore. Formulation of Ketoconazole ophthalmic ointment using cow ghee as a base and penetration enhancer. International research journal of Pharmacy.2016; 7(7).
- Rathore K.S, Nema R.K. An insight into Ophthalmic drug delivery system. International Journal of Pharmaceutical sciences and Drug research; 2009:1(1):1-5.
- Shulin Ding. Recent developments in ophthalmic drug delivery. Research focus.1998; Vol 1: No 8.
- Anchal Tyagi, Pramod Kumar Sharma, Rishabha Malviya. Novel technology and future propects of ocular drug delivery. Journal of basic pharmacology and toxicology.2017; 1(4):1-8.
- Koichi Baba, Yuji Tanaka, Akira Kubota, Hitoshi Kasai, Shunji Yokokura, Hachiro Nakanishi, Kohji Nishida. A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolysable dye. Journal of Controlled release.Elsevier.2011; 153:278-287.
- Priyanka Agarwal, Di Huang, Sachin S, Thakur, Ilva D Rupenthal. Chapter 4 Nanotechnology for ocular drug delivery. Design of Nanostructures for versatile therapeutic applications. Elsevier.2018; 137-188p.
- James N. Chang. Recent advances in ophthalmic drug delivery. Handbook of Non-Invasive Drug delivery system.Elsevier.2010.165-192p.
- M.J, Barea, M. J. Jenkins, M. H. Gaber, R. H. Bridson. Evaluation of liposomes coated with a pH responsive polymer. International journal of pharmaceutics.Elsevier.2010; 402:89-94.
- Yerikala Ramesh, Chandrasekhar B, Kothapalli, Jayachandra Reddy Peddappi Reddigari. A novel approaches on Ocular drug delivery system. Journal of drug delivery and therapeutics. 2017; 7(6):117-124.
- Smita Nayak, Madhuri Jadhav, Vaidhun Bhaskar. Recent advances in Ocular drug delivery system. Research Journal of Pharmacy and Technology.2016; 9(7).
- Vijay Shinde, P. Amsa, S. Tamizharasi, D. Karthikeyan, T. Shivakumar, Aniket Kale. Formulation and Characterization of Eudragit RS 100 Nanosuspension for ocular delivery of Indomethacin. Research Journal of Pharmacy and Technology. 2010; 3(3).
- Karthikeyan D, Pandey V. P. Preparation and Invitro characterization of Diclonefac sodium Niosomes for ocular use. Research Journal of Pharmacy and Technology. 2009; 2(4).
- Yumei Wu, Yuanyuan Liu, Xinyue Li, Dereje Kebebe. Research progress of in-situ gelling ophthalmic drug delivery system. Asian journal of Pharmaceutical sciences.Elsevier.2018; 000:1-15.
- S. K. Gupta, I. L. Singhvi. Insitu gelling system and other possible innovative approach for Ocular Disease: A review. Research Journal of Pharmacy and Technology.2011; 4(6).
- Ashwini S. Mhetre, Ajay D. Shinde. Study of Intraocular permeability enhancement of Brimonidine tartrate by formulation in its insitu thermoreversible gel. Asian journal of Pharmaceutics.2016; 10(4):S527.
- K. H. Hsu, S. Gause, A. Chauhan. Review of ophthalmic drug delivery by Contact lenses. Journal of drug delivery Science Technology.Elsevier.2014; 24(2):123-35.
- Prina Mehta, Ali Al-Kinani, Muhammad Sohail Arshad, Ming-Wei Chang, Raid G Alany. Development and Characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers. International Journal of Pharmaceutics.2017; 532(1), pp408-420.
- Li Gan, Yong Gan, Chunliu Zhu, Xinxin Zhang, Jiabi Zhu. Novel microemulsion insitu electrolyte triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A:Invitro and invivo results. Elsevier.2009; 365(1-2):143-9.
- Jae Hwan Jung, Bryce Chiang, Hans E. Grossniklaus, Mark R Prausnitz. Ocular drug delivery targeted by Iontophoresis in the suprachoroidal space using Microneedle. Journal of controlled release. Elsevier. 2018; 277:14-22.
- Kurtis Moffatt, Yujing Wang, Thakur Raghu Raj Singh, Ryan F Donnelly. Microneedles for enhanced transdermal and intraocular drug delivery. Current opinion Pharmacology.Elsevier.2017; 36:14-21.
- Rathore K. S, Nema R.K. Review on Ocular inserts. International Journal of Pharm Tech Research.2009; Vol 1, No 2, pp 164-169.
- Gerard Lee See, Ayano Sagesaka, Hazuki Torizuka, Hiroaki Todo, Kenji Sugibayashi. Iontophoresis aided drug delivery into the eyeball via eyelid skin. Journal of drug delivery science and Technology.Elsevier.2018; 47:380-385.
- Prina Mehta, Rita Haj Ahmad, All Al-Kinani. Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug delivery devices. Therapeutic delivery.2017; 8(7):521-541.
- Shambhavi Shahi, Shirish Deshpande. Iontophoresis: An approach to drug delivery enhancement. International journal of pharmaceutical sciences and research; 2017.
- C.J.F Bertens, M. Gijs, R. M. M. A. Nuijts, F.J.H.M. Van den Biggelaar. Topical drug delivery devices. A review. Experimental Eye Research.Elsevier.2018; 168:149-60.
- Di Huang, Ying Shan Chen, Ilva D. Rupenthal. Overcoming ocular drug delivery barriers through the use of physical forces. Advanced drug delivery reviews. Elsevier.2018; 126:96-112.
- Chhavi Gupta, Anuj Chanuhan. Ophthalmic delivery of Cyclosporine A by Punctal plugs. Journal of Controlled release.Elsevier.2011; 150:70-76.
- Karthikeyan D, Sonkar S, Pandey V.P, Nandha Kumar J, Sengottuvelu S, Bhowmick M, Shivakumar T. Development and Characterization of Modified Ocular Inserts with improved ocular compatibility. Research Journal of Pharmacy and Technology.2008; 1(2):93-9.
- Deepak Nautiyal, Vikram Singh, Sahadat Ali. Formulation and Evaluation of Sustained release of Ofloxacin ocular inserts. Research journal of Pharmacy and Technology.2012; 5(12).
- Karthikeyan D, Vijaikumar S, Pandey V.P, Nandha Kumar J, Sengottuvelu S, T Shivakumar. Preparation and evaluation of ocular inserts for controlled delivery of Ciprofloxacin hydrochloride. Research journal of Pharmacy and Technology.2008; 1(1).
- Preeti K. Suresh, Geeta Barsa, Abhishek K. Sah, Sanjay J. Daharwal. Ocular implants as drug delivery device in ophthalmic therapeutics: An overview. Research journal of Pharmacy and Technology. 2014; 7(6).
- Karthikeyan D, Bhowmick M, Pandey VP, Sengottuvelu S, Sonkar S, Gupta N, Mohod V, Shivakumar T. Design and Evaluation of Ofloxacin Extended Release Ocular Inserts for once a day therapy. Research Journal of Pharmacy and Technology. 2008; 1(4).
- A Review on Ethosomes for Transdermal Application
Abstract Views :533 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund. (Affiliated to JSS Academy of Higher Education and Research, Mysuru), IN
1 Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund. (Affiliated to JSS Academy of Higher Education and Research, Mysuru), IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 7 (2019), Pagination: 3133-3143Abstract
Skin is a constitutional and the most easily manageable organ of the body. The objective of transdermal drug delivery system is to cross the stratum corneum. Various methods have been used to escalate the penetration rate of drugs. Ethosomes are the most pioneering vesicular system with eminent level of ethanol present in it which ensures better penetration of drugs into deeper strata of skin. Ethosomes are mainly focused on the transdermal delivery of drugs. Transdermal delivery of drugs is a self-reliant, distinct dosage form which delivers the drug via skin at a meticulous rate to the blood when applied to the skin. These carriers are premeditated for their proficient conveyance of drugs or therapeutic agents. Even though ethosomal systems are theoretically sophisticated, they are much easier to prepare, safer and efficient when used in combination which has a high impact on their application. This article provides a detailed information about the ethosomal system, the types of ethosomes based on their components to classical ethosomes, binary ethosomes and transethosomes and their method of preparation. Evaluation parameters such as vesicle morphology, vesicle size and size distribution, zeta potential, percent entrapment efficiency, permeation distinctiveness, surface tension measurement, physical stability, transition temperature, vesicle-skin interaction study are deliberated. Numerous applications of ethosomes to treat various diseases were also discussed in this article. Ethosomes offers an enormous number of significant aids including improving the efficacy of drug, enhancing patient acquiescence and comfort and reducing the total cost of treatment. Ethosomes are innovative carriers for the delivery of therapeutic agents.Keywords
Transdermal, Ethosomes, Skin, Vesicle, Ethanol.References
- Arda O, Göksügür N, Tüzün Y. Basic histological structure and functions of facial skin. Clin Dermatol. 2014, 32(1):3–13.
- Norlén L. Current understanding of skin barrier morphology. Skin Pharmacol Physiol. 2013; 26(4–6): 213–6.
- Abdulbaqi IM, Darwis Y, Khan NAK, Assi RA, Khan AA. Ethosomal nanocarriers: The impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine. 2016, 11:2279–304.
- Sindhu RK, Chitkara M, Kaur G, Jaiswal P, Kalra A. Skin Penetration Enhancer’ s in Transdermal Drug Delivery Systems. Research Journal of Pharmacy and Technology. 2017; 10(June):1809–15.
- Ali S, Shabbir M, Shahid N. The Structure of Skin and Transdermal Drug Delivery System- A Review, Research journal of pharmacy and technology, 2015, 8(February):103–9.
- Kurmi B Das, Tekchandani P, Paliwal R, Paliwal SR. Transdermal Drug Delivery: Opportunities and Challenges for Controlled Delivery of Therapeutic Agents Using Nanocarriers. Curr Drug Metab. 2017, 18(5): 481–95.
- Rizwan M, Aqil M, Talegaonkar S, Azeem A, Sultana Y, Ali A. Enhanced Transdermal Drug Delivery Techniques: An Extensive Review of Patents. Recent Pat Drug Deliv Formul. 2009, 3(2):105–24.
- Godin B, Touitou E. Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 2007, 59(11):1152–61.
- Erode T, Road P, Palayam V. Formulation and Evaluation of Iontophoretic Transdermal Delivery of Atorvastatin Calcium. Research Journal of Pharmacy and Technology. 2011; 4(May):730–4.
- Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: Current and future prospects. Drug Deliv J Deliv Target Ther Agents. 2006; 13(3):175–87.
- Kapoor D, Patel M, Singhal M. Innovations in Transdermal drug delivery system. Int Pharm Sci. 2011; 1(1): 54–61.
- Li G, Fan Y, Fan C, Li X, Wang X, Li M, et al. Tacrolimus-loaded ethosomes: Physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm. 2012, 82(1):49–57.
- Mahmood S, Mandal UK, Chatterjee B. Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation. Int J Pharm. 2018, 542(1–2):36–46.
- Wilson V, Siram K, Rajendran S, Sankar V. Development and evaluation of finasteride loaded ethosomes for targeting to the pilosebaceous unit. Artif Cells, Nanomedicine Biotechnol. 2017; 0(0):1–10.
- Indora N, Kaushik D. Design, development and evaluation of ethosomal gel of fluconazole for topical fungal infection. International Journal of Engineering Science Invention Research & Development, 2015; I(Viii).
- He R, Cui D xiang, Gao F. Preparation of fluorescence ethosomes based on quantum dots and their skin scar penetration properties. Mater Lett. 2009, 63(20):1662–4.
- Mistry A, Ravikumar P. Development and Evaluation of Azelaic Acid Based Ethosomes for Topical Delivery for the Treatment of Acne. Indian Journal of Pharmaceutical Education and Research. 2016, 50(3).
- Patel A, Sharma RK, Trivedi M, Panicker A, Science V, Mp AHJ. Ethosomes : A Novel Tool for Transdermal Drug Delivery. Research Journal of Pharmacy and Technology. 2013; 6(August):838–41.
- Chourasia MK, Kang L, Yung S. Results in Pharma Sciences Nanosized ethosomes bearing ketoprofen for improved transdermal delivery. Results Pharma Sci. 2011; 1(1):60–7.
- Pandey S, Misra SK, Sharma N. Ethosomes- A Novelize Vesicular Drug Delivery System. Research Journal of Pharmacy and Technology. 2017; 10(September):3223–32.
- Rani S, David N, Hui MS, Pin CF, Ci FY, Rajabalaya R, et al. Formulation and in vitro evaluation of ethosomes as vesicular carrier for enhanced topical delivery of isotretinoin.International journal of drug delivery. 2013; 5:28–34.
- Liu YS, Wen CF, Yang YM. Development of ethosome-like catanionic vesicles for dermal drug delivery. J Taiwan Inst Chem Eng. 2012; 43(6):830–8.
- Marto J, Vitor C, Guerreiro A, Severino C, Eleutério C, Ascenso A, et al. Ethosomes for enhanced skin delivery of griseofulvin. Colloids Surfaces B Biointerfaces. 2016; 146:616–23.
- Mishra AD, Khunt DM, Ghayal AH, Patel CN, Shah DR. Formulation and Optimization of Ethosomes for Transdermal Delivery of Felodipine.Research Journal of Pharmacy and Technology. 2012, 5(December):1509–17.
- Cortesi R, Romagnoli R, Drechsler M, Menegatti E, Zaid AN, Ravani L, et al. Liposomes- and ethosomes-associated distamycins: a comparative study.Journal of Liposome Research. 2010; 20(October 2009):277–85.
- Transdermal Delivery of Ciclopirox Olamine via Ethosomal and Liposomal Carrier, Research Journal of Pharmacy and Technology. 2011; 4(8):1207–11.
- Fan C, Li X, Zhou Y, Zhao Y, Ma S, Li W, et al. Enhanced topical delivery of tetrandrine by ethosomes for treatment of Arthritis. Biomed Res Int. 2013; 2013.
- D JP, L RD, Ariya R, Kumari T. Formulation and In vitro Characterization of Ketoconazole Liposomal Gel for Transdermal Delivery. Research Journal of Pharmacy and Technology. 2017; 10(January):205–12.
- Aggarwal D, Nautiyal U. Ethosomes: A review. International Journal on Pharmaceutical and Medicinal research. 2016; 4(1):354–63.
- Parashar T, Soniya, Sachan R, Singh V, Singh G, Tyagi S, et al. Review Article ETHOSOMES: A recent vesicle of transdermal drug delivery system. Int J Res Dev Pharm Life Sci. 2013, 2(2):285–92.
- Madoria N, Pathodiya M, Tiwari A. Aceclofenac Loaded Vesicles: A Comparative Study between Various Vesicular Systems. Research Journal of Pharmacy and Technology. 2012, 5(August):1130–8.
- Jain S, Patel N, Madan P, Lin S. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharm Dev Technol. 2015, 20(4):473–89.
- Maestrelli F, Capasso G, González-Rodríguez ML, Rabasco AM, Ghelardini C, Mura P. Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res. 2009, 19(4):253–60.
- Mura P, Maestrelli F, González-Rodríguez ML, Michelacci I, Ghelardini C, Rabasco AM. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm. 2007, 67(1):86–95.
- Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - Novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J Control Release. 2000, 65(3):403–18.
- Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. International Journal of Pharmaceutics. 2007, 62(2):133–7.
- Maheshwari RGS, Tekade RK, Sharma PA, Darwhekar G, Tyagi A, Patel RP, et al. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment. Saudi Pharm J. 2012, 20(2):161–70.
- Parmar P, Mishra A, Pathak A. Preparation and Evaluation of Ethosomal Gel of Clotrimazole for Fungal Infection by Mechanical Dispersion Method. Current Research in Pharmaceutical sciences. 2016; 06(02):45–9.
- Gondkar SB, Patil NR, Saudagar RB. Formulation Development and Characterization of Etodolac Loaded Transethosomes for Transdermal Delivery. Research Journal of Pharmacy and Technology. 2017, 10(September):3049–56.
- Nidhi N, Sunil J, Ranjit S, Anand SV. Transdermal applications of ethosomes-a detailed review. J Liposome Res. 2018; 0(0):000.
- Pandey V, Golhani D, Shukla R. Ethosomes: Versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Deliv. 2015; 22(8): 988–1002.
- Xie J, Ji Y, Xue W, Ma D, Hu Y. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery. Colloids Surfaces B Biointerfaces. 2018; 172(May): 323–9.
- Jaiswal PK, Kesharwani S, Kesharwani R, Patel DK. ETHOSOME: A NEW TECHNOLOGY USED AS TOPICAL & TRANSDERMAL DELIVERY SYSTEM. J Drug Deliv Ther. 2016; 6(3):6–17.
- Garg BJ, Garg NK, Beg S, Singh B, Katare OP. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: Formulation optimization, in vitro evaluation and preclinical assessment. J Drug Target. 2016; 24(3): 233–46.
- Bodade SS, Shaikh KS, Kamble MS, Chaudhari PD. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug. Drug Deliv. 2013; 20(1):40–6.
- Yan Y, Zhang H, Sun J, Wang P, Dong K, Dong Y, et al. Enhanced transdermal delivery of sinomenine hydrochloride by ethosomes for anti-inflammatory treatment. J Drug Deliv Sci Technol. 2016, 36: 201–7.
- Shen LN, Zhang YT, Wang Q, Xu L, Feng NP. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 2014, 460(1–2): 280–8.
- Garg AK, Negi LM, Chauhan M. Gel containing ethosomal vesicles for transdermal delivery of aceclofenac. International Journal of Pharmacy and Pharmaceutical sciences 2010; 2.
- Madsen JT, Vogel S, Johansen JD, Sørensen JA, Andersen KE, Nielsen JB. Percutaneous penetration characteristics and release kinetics of contact allergens encapsulated in ethosomes. Expert opinion on Drug delivery.2011; 30(August 2010):38–44.
- Aute PP, Kamble MS, Chaudhari PD, Bhosale A V, Modern PES, No S. Review Article A COMPREHENSIVE REVIEW ON ETHOSOMES. International journal of research and development in pharmacy and life sciences. 2012; 2(1):218–24.
- Zhang Z, Wo Y, Zhang Y, Wang D, He R, Chen H, et al. In vitro study of ethosome penetration in human skin and hypertrophic scar tissue. Nanomedicine Nanotechnology, Biol Med. 2012; 8(6):1026–33.
- Khan NR, Wong TW. Microwave-aided skin drug penetration and retention of 5-fluorouracil-loaded ethosomes. Expert Opin Drug Deliv. 2016; 13(9):1209–19.
- Godin B, Touitou E. Erythromycin Ethosomal Systems Physicochemical Characterization and Enhanced Antibacterial Activity. Current Drug Delivery. 2005; 269–75.
- Godin B, Touitou E, Rubinstein E, Athamna A, Athamna M. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. Journal of Antimicrobial chemotherapy. 2005; (April):989–94.
- Padula C, Sartori F, Marra F, Santi P. The Influence of Iontophoresis on Acyclovir Transport and Accumulation in Rabbit Ear Skin. Pharmaceutical paper. 2005, 22(9):1–6.
- Horwitz E, Pisanty S, Czerninski R, Helser M, Eliav E. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis.Oral surgery oral medicine oral pathology. 1999; 700–5.
- Zitzmann M, Nieschlag E. Hormone substitution in male hypogonadism. Molecular and cellular endocrinology. 2000; 161:73–88.
- Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KIME, Mazer NA, et al. Pharmacokinetics, Efficacy, and Safety of a Permeation- Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men.The journal of clinical endocrinology and metabolism. 2015, 84(10).
- Ainbinder D, Touitou E. Testosterone Ethosomes for Enhanced Transdermal Delivery. Drug delivery.2005; 297–303.
- Mahmood I, Sahajwalla C. Clinical Pharmacokinetics and Pharmacodynamics of Buspirone, an Anxiolytic Drug. Clinical Pharmacokinetics.1999; 36(4):277–87.
- Ohlsen RI, Pilowsky LS. The place of partial agonism in psychiatry: recent developments. Journal of Psychopharmacology 2015; 19(4).408-413.
- Shumilov M, Touitou E. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies. Int J Pharm. 2010; 387(1–2):26–33.
- Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 2000; 21:1879–85.
- Touitou E, Godin B, Weiss C. Enhanced Delivery of Drugs Into and Across the Skin by Ethosomal Carriers. Drug Development Research. 2000; 415:406–15.
- Ahad A, Raish M, Al-mohizea AM, Al-jenoobi FI, Alam MA. International Journal of Biological Macromolecules Enhanced anti-inflammatory activity of carbopol loaded meloxicam nanoethosomes gel. Int J Biol Macromol. 2014, 67:99–104.
- Marianecci C, Rinaldi F, Marzio L Di, Pieretti S, Celia C, Iannone M, et al. Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models. International Journal of Nanomedicine. 2014; 635–51.
- Shumilov M, Bercovich R, Duchi S, Ainbinder D, Touitou E. Ibuprofen Transdermal Ethosomal Gel: Characterization and Efficiency in Animal Models. Journal of biomedical nanotechnology. 2010; 6(5):569–76.
- Fang Y, Tsai Y, Wu P, Huang Y. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. International Journal of Pharmaceutics.2008; 356:144–52.
- Ainbinder D, Touitou E. A new approach for skin tumor treatment: from delivery system characterization to in vivo evaluation. Drug Deliv. and Transl. Res.2011; 53–65.
- Bhosale SS, Avachat AM. system of valsartan with preclinical assessment in Wistar albino rats. Journal of Liposome Research. 2013; 2104(2):119–25.
- Rao Y, Zheng F, Zhang X, Gao J, Liang W. In Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers. AAPS Pharm SciTech. 2008; 9(3):860–5.
- Size and CT density of iodine-containing ethosomal vesicles obtained by membrane extrusion: Potential for use as computed tomography (CT) contrast agents. Biotechnology Journal. 2013; 1–7.
- Shin H, Cho Y, Lee K, Lee C, Choi BW, Kim B. Synthesis and characterization of ethosomal contrast agents containing iodine for computed tomography (CT) imaging applications. Journal of Liposome Research. 2014; 2104(2):124–9.